Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11056 |
DLK-IN-1
|
DNA Alkylation | DNA Damage/DNA Repair |
DLK-IN-1 is a selective oral active inhibitor of bisleucine zipper kinase (DLK, MAP3K12) with Ki of 3 nM. DLK-IN-1 is active in the Alzheimer's disease model, retains excellent CNS permeability, and after multiple days of administration, its concentration |